Becton Dickinson, also known as BD, is one of the largest international medical technology companies that develops, produces and sells disposable medical devices, device systems and reagents. BD supplies hospitals, health care facilities, life scientists, clinical laboratories and the pharmaceutical industry.
According to Becton Dickinson's latest financial reports the company's current revenue (TTM ) is โน1.781 Trillion. an increase over the revenue in the year 2023 that were of โน1.622 Trillion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2024 | โน1.770 T | 9.12% |
2023 | โน1.622 T | 4.65% |
2022 | โน1.550 T | 7.57% |
2021 | โน1.441 T | 8.26% |
2020 | โน1.331 T | 7.6% |
2019 | โน1.237 T | 3.73% |
2018 | โน1.193 T | 52.53% |
2017 | โน782.17 B | -7.31% |
2016 | โน843.86 B | 13.21% |
2015 | โน745.42 B | 38.67% |
2014 | โน537.57 B | 6.52% |
2013 | โน504.66 B | 18.52% |
2012 | โน425.79 B | 3.77% |
2011 | โน410.31 B | 27.09% |
2010 | โน322.84 B | -4.84% |
2009 | โน339.26 B | -1.53% |
2008 | โน344.53 B | 33.75% |
2007 | โน257.60 B | -0.93% |
2006 | โน260.01 B | 4.67% |
2005 | โน248.40 B | 14.91% |
2004 | โน216.17 B | 1.86% |
2003 | โน212.23 B | 6.91% |
2002 | โน198.52 B | 7% |
2001 | โน185.53 B | 9.7% |
2000 | โน169.11 B | 10.87% |
1999 | โน152.53 B | 12.66% |
1998 | โน135.39 B | 20.62% |
1997 | โน112.25 B | 12.09% |
1996 | โน100.14 B |